Dolby Laboratories To Replace Staar Surgical In S&P MidCap 400; Staar Surgical To Replace Urstardt Biddle Properties In S&P SmallCap 600
Portfolio Pulse from Benzinga Newsdesk
Dolby Laboratories (DLB) will replace Staar Surgical (STAA) in the S&P MidCap 400 index, while Staar Surgical will replace Urstadt Biddle Properties (UBA) in the S&P SmallCap 600 index.
August 18, 2023 | 1:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Dolby Laboratories is set to join the S&P MidCap 400, which could increase its visibility and potentially its stock price.
Being included in an index like the S&P MidCap 400 often leads to increased visibility and demand for a company's stock, which can drive up the price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEUTRAL IMPACT
Staar Surgical is being replaced in the S&P MidCap 400 by Dolby Laboratories, but will join the S&P SmallCap 600, replacing Urstadt Biddle Properties.
While being removed from an index can lead to decreased demand for a stock, Staar Surgical is also joining another index, which could offset any potential negative impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Urstadt Biddle Properties is being replaced in the S&P SmallCap 600 by Staar Surgical, which could potentially lead to a decrease in its stock price.
Being removed from an index like the S&P SmallCap 600 can lead to decreased visibility and demand for a company's stock, which can drive down the price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100